Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis.

Authors :: Meier JJ
Bardtrum L
Cheng AYY
Malling B
Montanya E
Wagner L
Pratley RE
Source :: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Apr; Vol. 25 (4), pp. 1130-1135. Date of Electronic Publication: 2023 Jan 17.
Publication Year :: 2023

Subjects :: Humans
Glucagon-Like Peptides adverse effects
Hypoglycemic Agents adverse effects
Weight Loss
Body Weight
Diabetes Mellitus, Type 2 chemically induced

Full Text Access

Tools